期刊文献+

过继免疫细胞治疗预防肝癌肝移植术后复发的新思路探究 被引量:5

下载PDF
导出
摘要 我国是肝病大国,也是全球原发性肝癌(肝癌)的第一大国。我省更是肝炎、终末期肝病、肝癌的重灾区,广东地区肝脏疾病发病率高达近20%,严重危害着民众的健康。肝细胞癌(hepatocellular carcinoma,HCC)是我国最常见的恶性肿瘤之一,其死亡率居恶性肿瘤死亡率的第2位,每年大约有11万人死于HCC,占全世界HCC死亡人数的45%。
出处 《器官移植》 CAS CSCD 2014年第3期131-136,共6页 Organ Transplantation
基金 国家十二五科技重大专项课题(2012ZX10002016-023 2012ZX10002017-005) 国家自然科学基金(81172036 81372243 81370555 81301331)
  • 相关文献

参考文献37

  • 1Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [ J ]. CA Cancer J Clin, 2005, 55 (2) : 74-108.
  • 2世界卫生组织.癌症实况报道(第297号)[EB/OL].[2014-02-01].http://www.who.int/mediaeentre/factsheets/fs297/zh/index.html.
  • 3Kim HR, Cheon SH, Rha SY, et al. Treatment of recurrent hepatocellular carcinoma after liver transplantation[ J]. Asia Pac J Clin Oncol, 2011, 7 (3) : 258-269.
  • 4Roayaie S, Schwartz JD, Sung MW, et al. Recurrence of hepatocelludar carcinoma after liver transplant: patterns and prognosis[J]. Liver Transpl, 2004, 10 (4) : 534- 540.
  • 5Couzin-Frankel J. Immune therapy steps up the attack [J]. Science, 2010, 330 (6003) : 440- 443.
  • 6No authors listed. Breakthrough of the year. areas to watch[J]. Science, 2012, 338 (6114): 1528-1529.
  • 7Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age[J]. Nature, 2011, 480 (7378): 480- 489.
  • 8Topalian SL, Weiner G J, Pardoll DM. Cancer immunotherapy comes of age[J]. J Clin Oncol, 2011, 29 (36) : 4828-4836.
  • 9Couzin-Frankel J. Breakthrough of the year 2013. Cancerirnmunotherapy [ J ] . Science, 2013, 342 ( 6165 ) : 1432-1433.
  • 10Lizée G, Overwijk WW, Radvanyi L, et al. Harnessing the power of the immune system to target cancer [J]. Annu Rev Med, 2013, 64: 71-90.

同被引文献82

  • 1张晶,谢幸,叶大风.黏附分子与肿瘤免疫逃逸[J].实用肿瘤杂志,2004,19(5):449-452. 被引量:18
  • 2周伟平,吴孟超,陈汉,姚小平,钱光相,杨甲梅,屠振兴,崔贞福.肝癌切除加免疫化疗对术后复发的影响[J].中华外科杂志,1995,33(1):35-37. 被引量:32
  • 3Forner A,Llovet JM,Bruix J.Hepatocellular carcinoma[J].Lancet,2012,379(9822):1245-1255.
  • 4Malek NP,Schmidt S,Huber P,et al.The diagnosis and treatment of hepatocellular carcinoma[J].Dtsch Arztebl Int,2014,111(7):101-106.
  • 5Byam J,Renz J,Millis JM.Liver transplantation for hepatocellular carcinoma[J].Hepatobiliary Surg Nutr,2013,2(1):22-30.
  • 6Mazzaferro V,Regalia E,Doci R,et al.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis[J].N Engl J Med,1996,334(11):693-699.
  • 7Yao FY,Ferrell L,Bass NM,et al.Liver transplantation for hepatocellular carcinoma:expansion of the tumor size limits does not adversely impact survival[J].Hepatology,2001,33(6):1394-1403.
  • 8Herrero JI,Sangro B,Pardo F,et al.Liver transplantation in patients with hepatocellular carcinoma across Milan criteria[J].Liver Transpl,2008,14(3):272-278.
  • 9Mazzaferro V,Llovet JM,Miceli R,et al.Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria:a retrospective,exploratory analysis[J].Lancet Oncol,2009,10(1):35-43.
  • 10Toso C,Asthana S,Bigam DL,et al.Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database[J].Hepatology,2009,49(3):832-838.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部